In December 2026, Kelly Osbourne hit back at critics who commented on her dramatic weight loss online ...

A total diet replacement program before colorectal cancer surgery appears feasible and safe for patients with excess weight ...

Retatrutide, originally developed by Eli Lilly, has found a loyal fan base—even though clinical trials of the drug still ...

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly.

San Francisco-based pharmaceutical company OKAVA is investigating an implant that slowly releases a GLP-1 medication for up ...

GLP-1 agonist drugs essentially mimic the hormone’s action. Quite a few have been developed, including semaglutide, tirzepatide, liraglutide, and exenatide, which have brand names like Ozempic, ...

GLP-1 RAs are safe and efficacious for adults with IBD, with no increased risk for flare-ups, hospitalization, corticosteroid use, or operation.

Emily McNutt is a journalist and editorial leader with extensive experience covering a range of topics from travel rewards to product reviews and financial news. With a passion for accurate reporting ...

We asked experts about the buzzy new medication.

Game-changing news: Medicare Part D will cover popular weight loss drugs like Wegovy and Ozempic starting in 2026, with ...

A check mark. It indicates that the relevant content has been reviewed and verified by an expert Our stories are reviewed by medical professionals to ensure you get the most accurate and useful ...

MSK Breast Medical Oncologist Sherry Shen, MD, is an expert in the relationship between obesity, diet, and cancer. Her research includes studying new weight loss drugs such as Zepbound, Wegovy, and ...